Miprogen 200mg Tablet SR is a sustained-release formulation containing 200mg of natural micronized progesterone, a vital hormone essential for various physiological processes. The tablet is designed to provide a controlled release of progesterone over an extended period, ensuring a stable serum concentration. This unique formulation allows for a consistent therapeutic effect, reducing the frequency of dosing while minimizing fluctuations in serum levels. Miprogen 200mg Tablet SR is indicated for the treatment of various gynecological and endocrinological disorders, including dysmenorrhea, premenstrual syndrome, and secondary amenorrhea, as well as for hormone replacement therapy in postmenopausal women. The tablet is contraindicated in women with a history of breast cancer, liver disease, or undiagnosed abnormal uterine bleeding. Additionally, Miprogen 200mg Tablet SR is not recommended for use during pregnancy or in women with a history of thromboembolic events or stroke. As with any medication, patients should be carefully monitored for potential adverse effects, which may include dizziness, headache, or fatigue.